newsfilter
← Latest News
GlobeNewswire·

SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for